Current Rating and Its Implications
MarketsMOJO currently assigns a 'Sell' rating to Niva Bupa Health Insurance Company Ltd, indicating a cautious stance towards the stock. This rating suggests that investors should consider reducing exposure or avoiding new positions in the stock, given the prevailing risks and performance indicators. The rating was revised from 'Strong Sell' to 'Sell' on 30 Mar 2026, reflecting a modest improvement in the company’s outlook, but still signalling concerns that warrant attention.
How the Stock Looks Today: An Overview of Fundamentals
As of 03 May 2026, Niva Bupa Health Insurance operates within the insurance sector as a small-cap entity. The company’s Mojo Score currently stands at 37.0, which corresponds to the 'Sell' grade. This score reflects a composite assessment of various parameters including quality, valuation, financial trend, and technicals.
Quality Assessment
The quality grade for Niva Bupa is classified as 'average'. This suggests that while the company maintains a reasonable operational framework and business model, it does not exhibit standout strengths in areas such as profitability, management efficiency, or competitive positioning. Investors should note that average quality may limit the stock’s ability to generate superior returns in challenging market conditions.
Valuation Considerations
Valuation is a critical factor in the current rating, with the stock deemed 'risky' on this front. The company is trading at valuations that are considered elevated relative to its historical averages and sector peers. This elevated valuation is compounded by the presence of negative EBITDA, which raises concerns about the sustainability of earnings and cash flow generation. Such a valuation profile suggests that the stock may be vulnerable to price corrections if operational performance does not improve.
Financial Trend Analysis
The financial grade is assessed as 'flat', indicating a lack of significant growth or deterioration in key financial metrics. The latest quarterly results for December 2025 reveal a challenging environment, with the company reporting a net loss after tax (PAT) of ₹-87.64 crores, representing a steep decline of 478.5% compared to the previous four-quarter average. Additionally, profit before depreciation, interest, and taxes (PBDIT) and profit before tax less other income (PBT less OI) both stood at ₹-94.21 crores, marking the lowest levels recorded. Despite these setbacks, the company’s profits have risen by 161% over the past year, indicating some recovery from earlier lows.
Technical Outlook
The technical grade is described as 'sideways', reflecting a lack of clear directional momentum in the stock price. Recent price movements show mixed performance: a one-day decline of 0.42%, a modest weekly gain of 0.55%, and a strong monthly increase of 11.85%. However, over longer periods, the stock has underperformed, with a three-month decline of 0.34%, a six-month gain of 4.77%, a year-to-date rise of 3.88%, and a one-year loss of 3.65%. This sideways trend suggests that the stock is consolidating, with investors awaiting clearer signals before committing further capital.
Performance Relative to Benchmarks
Over the past three years, Niva Bupa has consistently underperformed the BSE500 benchmark index. The stock’s one-year return of -3.98% contrasts with the broader market’s positive trends, highlighting challenges in delivering shareholder value. This underperformance, combined with the company’s financial and valuation concerns, underpins the cautious 'Sell' rating.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
Investor Takeaways
For investors, the 'Sell' rating on Niva Bupa Health Insurance Company Ltd signals caution. The combination of average quality, risky valuation, flat financial trends, and sideways technicals suggests that the stock currently faces headwinds that may limit upside potential. The company’s recent losses and negative EBITDA highlight operational challenges that need to be addressed before a more favourable outlook can be considered.
Investors should closely monitor upcoming quarterly results and any strategic initiatives aimed at improving profitability and cash flow. Given the stock’s small-cap status and sector dynamics, volatility may persist, and a disciplined approach to position sizing and risk management is advisable.
Summary
In summary, Niva Bupa Health Insurance Company Ltd’s current 'Sell' rating by MarketsMOJO, last updated on 30 Mar 2026, reflects a cautious stance based on comprehensive analysis of quality, valuation, financial trends, and technical factors. As of 03 May 2026, the stock exhibits mixed signals with operational losses and valuation risks outweighing recent improvements. Investors should weigh these factors carefully when considering exposure to this stock.
About MarketsMOJO Ratings
MarketsMOJO’s rating system integrates multiple dimensions of stock analysis to provide investors with actionable insights. The 'Sell' rating indicates that the stock is expected to underperform relative to the broader market or sector peers, and investors may want to consider reducing holdings or avoiding new purchases until conditions improve.
By focusing on up-to-date data and a balanced assessment of fundamentals and technicals, MarketsMOJO aims to help investors make informed decisions aligned with their risk tolerance and investment objectives.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
